News

Location:homepage  News

Congratulations on the publication of Yongping Dong and Gang Chen's paper by Analytical Chemistry!

发表时间:2016-03-10 阅读次数:325次

Electrochemiluminescent Sensing for Caspase-3 Activity Based on Ru(bpy)32+-Doped Silica Nanoprobe

Yong-Ping Dong†‡, Gang Chen†, Ying Zhou†‡, and Jun-Jie Zhu*†
† State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210093, China
‡ School of Chemistry and Chemical Engineering, Anhui University of Technology, Maanshan 243002, China
Anal. Chem., 2016, 88 (3), pp 1922–1929
DOI: 10.1021/acs.analchem.5b04379
Publication Date (Web): January 05, 2016
Copyright © 2016 American Chemical Society
*E-mail: jjzhu@nju.edu.cn.

Abstract

Abstract Image

Caspase-3 is one of the most frequently activated cysteine proteases during the apoptosis process and has been identified as a well-established cellular marker of apoptosis. In this study, a novel approach for the sensitive determination of caspase-3 activity was proposed using electrochemiluminescence (ECL) of Ru(bpy)32+-doped silica (Ru@SiO2) with tripropylamine (TPA) as coreactant. A nanocomposite containing gold nanoparticles (AuNPs), poly(dimethyldiallyl ammonium chloride) (PDDA), and multiwalled carbon nanotubes (CNTs) was fabricated as an ECL platform. The biotinylated DEVD-peptide (biotin-Gly-Asp-Gly-Asp-Glu-Val-Asp-Gly-Cys) was immobilized on the nanocomposite surface via the strong bonding interaction between AuNPs and the thiol group. Then the streptavidin-modified Ru(bpy)32+-doped silica (Ru@SiO2-SA) was immobilized on the ECL platform via the specific interaction between biotin and streptavidin to generate ECL signal. Caspase-3 can specifically recognize and cleave the N-terminus of DEVD, leading to the loss of the biotin label and the decrease of ECL intensity to determine the activity of caspase-3. The results revealed a new ECL avenue for the sensitive and specific monitor of caspase-3, and the platform could be utilized to evaluate anticancer drugs.